Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Klein

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Clinical Pharmacology and Therapeutics|November 23, 2006
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepineMikael Oscarson, Ulrich M Zanger, Oktay F Rifki, et al.
Frontiers in Pharmacology|December 6, 2021
Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid HomeostasisTamara Heintze, Denise Wilhelm, Thierry Schmidlin, et al.
Archives of Toxicology|March 23, 2017
Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levelsRoman Tremmel, Kristin Herrmann, Wolfram Engst, et al.
Frontiers in Pharmacology|November 20, 2015
Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8Maria Thomas, Stefan Winter, Britta Klumpp, et al.
Carcinogenesis|January 22, 2013
Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samplesKristin Herrmann, Fabian Schumacher, Wolfram Engst, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2013
The letrozole phase 1 metabolite carbinol as a novel probe drug for UGT2B7Jana C Precht, Werner Schroth, Kathrin Klein, et al.
Pharmacogenomics|April 21, 2009
Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidationAna M Gomes, Stefan Winter, Kathrin Klein, et al.
BMC Cancer|July 1, 2015
The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genesMaria Thomas, Christine Bayha, Kathrin Klein, et al.
Plos One|August 23, 2011
Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery diseaseYijing Zhang, Kathrin Klein, Aarathi Sugathan, et al.
Clinical Pharmacology and Therapeutics|April 19, 2012
PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivoKathrin Klein, Maria Thomas, Stefan Winter, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|November 23, 2006
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepineMikael Oscarson, Ulrich M Zanger, Oktay F Rifki, et al.
Frontiers in Pharmacology|December 6, 2021
Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid HomeostasisTamara Heintze, Denise Wilhelm, Thierry Schmidlin, et al.
Archives of Toxicology|March 23, 2017
Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levelsRoman Tremmel, Kristin Herrmann, Wolfram Engst, et al.
Frontiers in Pharmacology|November 20, 2015
Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8Maria Thomas, Stefan Winter, Britta Klumpp, et al.
Carcinogenesis|January 22, 2013
Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samplesKristin Herrmann, Fabian Schumacher, Wolfram Engst, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2013
The letrozole phase 1 metabolite carbinol as a novel probe drug for UGT2B7Jana C Precht, Werner Schroth, Kathrin Klein, et al.
Pharmacogenomics|April 21, 2009
Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidationAna M Gomes, Stefan Winter, Kathrin Klein, et al.
BMC Cancer|July 1, 2015
The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genesMaria Thomas, Christine Bayha, Kathrin Klein, et al.
Plos One|August 23, 2011
Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery diseaseYijing Zhang, Kathrin Klein, Aarathi Sugathan, et al.
Clinical Pharmacology and Therapeutics|April 19, 2012
PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivoKathrin Klein, Maria Thomas, Stefan Winter, et al.
Pageof 14